171 related articles for article (PubMed ID: 33111151)
1. A UPLC-MRM-MS method for comprehensive profiling of Amadori compound-modified phosphatidylethanolamines in human plasma.
He X; Li Z; Zhang Q
Anal Bioanal Chem; 2021 Jan; 413(2):431-443. PubMed ID: 33111151
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Identification of Amadori Compound-Modified Phosphatidylethanolamines in Human Plasma.
He X; Chen GY; Zhang Q
Chem Res Toxicol; 2019 Jul; 32(7):1449-1457. PubMed ID: 31188577
[TBL] [Abstract][Full Text] [Related]
3. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
Nakagawa K; Oak JH; Higuchi O; Tsuzuki T; Oikawa S; Otani H; Mune M; Cai H; Miyazawa T
J Lipid Res; 2005 Nov; 46(11):2514-24. PubMed ID: 16150834
[TBL] [Abstract][Full Text] [Related]
4. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples.
Oak JH; Nakagawa K; Miyazawa T
J Lipid Res; 2002 Mar; 43(3):523-9. PubMed ID: 11893788
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.
Shoji N; Nakagawa K; Asai A; Fujita I; Hashiura A; Nakajima Y; Oikawa S; Miyazawa T
J Lipid Res; 2010 Aug; 51(8):2445-53. PubMed ID: 20386060
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
Suzuki K; Nakagawa K; Miyazawa T
Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
[TBL] [Abstract][Full Text] [Related]
7. Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():280-3. PubMed ID: 16037249
[TBL] [Abstract][Full Text] [Related]
8. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Purification, and Mass Spectrometric Characterization of Stable Isotope-Labeled Amadori-Glycated Phospholipids.
He X; Zhang Q
ACS Omega; 2018 Nov; 3(11):15725-15733. PubMed ID: 30533579
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes--influence of glycation products on lipid peroxidation.
Breitling-Utzmann CM; Unger A; Friedl DA; Lederer MO
Arch Biochem Biophys; 2001 Jul; 391(2):245-54. PubMed ID: 11437356
[TBL] [Abstract][Full Text] [Related]
11. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of glycated phosphatidylethanolamines: evidence of oxidation in glycated polar head identified by LC-MS/MS.
Simões C; Simões V; Reis A; Domingues P; Domingues MR
Anal Bioanal Chem; 2010 Jul; 397(6):2417-27. PubMed ID: 20499053
[TBL] [Abstract][Full Text] [Related]
13. A convenient method for preparation of high-purity, Amadori-glycated phosphatidylethanolamine and its prooxidant effect.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():276-9. PubMed ID: 16037248
[TBL] [Abstract][Full Text] [Related]
14. Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions.
Oak J; Nakagawa K; Miyazawa T
FEBS Lett; 2000 Sep; 481(1):26-30. PubMed ID: 10984609
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of lipid quantification accuracy using HILIC and RPLC MS on the example of NIST® SRM® 1950 metabolites in human plasma.
Lange M; Fedorova M
Anal Bioanal Chem; 2020 Jun; 412(15):3573-3584. PubMed ID: 32240327
[TBL] [Abstract][Full Text] [Related]
16. Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography-mass spectrometry and hydrophilic interaction liquid chromatography-mass spectrometry.
Wolrab D; Chocholoušková M; Jirásko R; Peterka O; Holčapek M
Anal Bioanal Chem; 2020 Apr; 412(10):2375-2388. PubMed ID: 32078000
[TBL] [Abstract][Full Text] [Related]
17. Development of quantitation method for glycated aminophospholipids at the molecular species level in powdered milk and powdered buttermilk.
Kodate A; Otoki Y; Shimizu N; Ito J; Kato S; Umetsu N; Miyazawa T; Nakagawa K
Sci Rep; 2018 Jun; 8(1):8729. PubMed ID: 29880856
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation.
Percy AJ; Simon R; Chambers AG; Borchers CH
J Proteomics; 2014 Jun; 106():113-24. PubMed ID: 24769237
[TBL] [Abstract][Full Text] [Related]
19. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry.
Patteet L; Maudens KE; Sabbe B; Morrens M; De Doncker M; Neels H
Clin Chim Acta; 2014 Feb; 429():51-8. PubMed ID: 24291056
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a liquid chromatography-mass spectrometry method for rapid, accurate quantitation of malondialdehyde in human plasma.
Sobsey CA; Han J; Lin K; Swardfager W; Levitt A; Borchers CH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():205-212. PubMed ID: 27437618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
